Quest Bites: Will Pay $2 Billion for AmeriPath

CEO SUMMARY: From its inception in the mid-1990s as a pathology physician practice management (PPM) company, AmeriPath was a business that its investors created specifically to be sold. Now Quest Diagnostics Incorporated is stepping up to pay a princely ransom of $2 billion to make AmeriPath’s ultimate destiny become a reality. However, after the marriage, …

Quest Bites: Will Pay $2 Billion for AmeriPath Read More »

To access this post, you must purchase The Dark Report.

Quest Bites: Will Pay $2 Billion for AmeriPath

AmeriPath’s tires have been kicked by a host of buyers, so why Quest and why now?

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month